Why Eli Lilly (LLY) Stock Is Down Today

Why Eli Lilly (LLY) Stock Is Down Today

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments introduced significant uncertainty regarding the future pricing of the company’s weight-loss and diabetes drugs, Zepbound and Mounjaro. The drop occurred after President Donald Trump suggested that the price for the GLP-1 drug category, which Eli Lilly dominates alongside…

Read More
How a string of bad loans has bank investors hunting for hidden risks

How a string of bad loans has bank investors hunting for hidden risks

Big banks including JPMorgan Chase and Goldman Sachs had just finished taking victory laps after a blockbuster quarter when concerns emerged from an obscure corner of Wall Street, sending a collective shiver through global finance. Regional bank Zions late Wednesday disclosed a near total wipeout on $60 million in loans after finding “apparent misrepresentations” from…

Read More
Outlook for Oct. 20-24, 2025

Outlook for Oct. 20-24, 2025

Wall Street gets more information on corporate America next week, with third-quarter earnings shifting into high gear. There’s also important inflation data coming. The earnings season is off to a strong start, with financials topping expectations thanks to the likelihood of lower interest rates and greater merger and acquisition activity. S & P 500 earnings…

Read More